本轮融资将主要用于三大方向：加速新一代产品的研发、深化全球化市场布局，并加快顶尖人才的引进。超维景将通 过深化"高端科学仪器+脑机"的双轮驱动战略，进一步巩固技术壁垒，推动高时空分辨率神经观测技术在临床和脑疾 病干预领域的广泛应用，同时为我国高端科研仪器自主可控提供强有力的支撑。 近日，北京超维景生物科技有限公司（以下简称"超维景"）宣布完成超亿元B+轮融资。本轮融资由广东中医药大健康 基金、北京市医药健康产业投资基金、中关村科学城投资公司、海开控股集团、天津合盈海河脑机基金等五家具备深 厚产业背景的投资机构联合投资。 （超维景公众号） ...

此次对外投资旨在推进公司多元化战略布局，把握AI医疗影像行业的结构性机遇，切入精准医疗前沿领域。 （康众医疗公告） 脉得智能在2025年度的营业收入为5161万元，归母净利润约亏损2587万元。公司表示，投资后将有助于加快产品研 发、市场渠道建设与临床维护的进程，期望释放业绩增长潜力。 近日，康众医疗发布公告称，公司拟使用自有资金7000万元人民币以增资形式参股脉得智能科技（无锡）有限公司， 新增注册资本103万元。增资完成后，公司持有脉得智能7.3684%的股权。 ...

Core Insights - Apple is set to launch a series of new products in the coming weeks, including the iPhone 17e, upgraded iPads, and new Macs [1] iPhone 17e - The upcoming iPhone 17e will replace the iPhone 16e, featuring the same A19 chip as the iPhone 17 and introducing MagSafe charging [1] - It will also transition to Apple's latest in-house cellular and wireless communication chips, maintaining a price of $599 as a marketing strategy to highlight "more features for the same price" [1] - The iPhone 17e will be primarily targeted at emerging market users and enterprise customers, which are key focus areas for the company this year [1] iPad - New iPads are on the way, including an upgraded entry-level model and an iPad Air [3] - The entry-level iPad will feature the A18 chip, while the iPad Air will upgrade to the M4 chip, with the A18 supporting Apple Intelligence as a significant marketing point [3] - iPad sales showed strong performance during the holiday season, with revenue increasing by 6% year-over-year, surpassing Wall Street expectations [3] Mac - Apple plans to release several new Macs, including 14-inch and 16-inch MacBook Pros and a new MacBook Air with the M5 processor [4] - An upgraded Mac Studio desktop and a new Studio Display monitor are also expected, with the new MacBook aimed at competing with lower-priced Windows laptops and Chromebooks [4] - This new MacBook, with a screen size smaller than 13 inches and equipped with a chip similar to that of the iPhone, is designed to attract users to the Mac ecosystem, particularly in enterprise and emerging markets [4] Software - Apple is anticipated to release iOS 26.4 soon, which will include updates to some long-awaited Siri features [5] - The first beta version of iOS 26.4 is expected to be pushed to developers in the week of February 23, alongside the new MacBook Pro, which will sync with the ongoing macOS 26.3 update cycle [5] - The high-end MacBook Pro M4 version remains in high demand, indicating that new models are imminent, with a potential release as early as the week of March 2 [5]

Core Viewpoint - The State Administration for Market Regulation (SAMR) has established a comprehensive regulatory framework for the transportation of liquid food products in bulk, aimed at enhancing food safety through a series of new regulations and standards [1][3][4]. Group 1: Regulatory Framework - SAMR, in collaboration with relevant departments, has developed a series of regulatory documents including the "Directory of Key Liquid Foods for Road Bulk Transportation" and management guidelines to strengthen the oversight of liquid food transportation [1][2]. - The framework is designed to ensure food safety through a structured approach that includes a directory for permitted products, strict licensing procedures, traceability measures, and mandatory safety standards [3][4]. Group 2: Key Components of the Regulations - The "Directory" identifies 14 categories of liquid foods, including edible oils, condiments, alcoholic beverages, sugars, and starch sugars, which are subject to bulk transportation licensing [4][5]. - A management method has been established to regulate the licensing process, detailing requirements for transport containers, personnel qualifications, and responsibilities of all parties involved in the transportation chain [2][6]. - A traceability system has been implemented, requiring all parties (shippers, carriers, and receivers) to maintain accurate records throughout the transportation process to ensure accountability [3][7]. Group 3: Implementation Timeline and Compliance - The new licensing requirements will take effect on July 1, 2026, by which time all transport operators must obtain the necessary permits to transport the specified liquid food products [5][6]. - The regulations emphasize the importance of training and compliance, ensuring that all stakeholders are aware of their responsibilities under the new framework [5][8].

2月9日，克明食品发布公告称，公司控股子公司阿克苏兴疆牧歌食品股份有限公司2026年1月份销售生猪7.25万头，销 量环比下降9.47%，同比增长93.74%；销售收入6800.20万元，销售收入环比增长25.24%，同比增长68.29%。2026年1 月生猪销售数量和收入同比增长,主要系产能释放所致。 （企业公告） ...

近日，丽珠集团发布投资者调研记录，围绕公司在免疫领域的创新药莱康奇塔单抗及疫苗领域的研发进展进行了详细 交流。 在疫苗领域，公司正在推进流感灭活疫苗和重组人促卵泡激素注射液的研发。四价重组蛋白流感疫苗预计在2026年上 半年进入II期临床，而重组人促卵泡激素注射液预计在2026年内获批上市。公司强调将继续利用AI技术提升研发效 率，缩短研发周期，进一步增强市场竞争力。 公告中提到，在免疫领域，莱康奇塔单抗作为公司的核心标志性成果，目前正在进行中重度银屑病及强直性脊柱炎的 临床研究。其中银屑病适应症已申报上市并纳入CDE优先审评，预计最快在今年底获批。强直性脊柱炎适应症预计在 2026年二季度申报上市。III期临床研究显示，莱康奇塔单抗组第12周PASI100应答率为49.5%，显著优于司库奇尤单抗 的40.2%。此外，公司还启动了海外合作洽谈，未来将探讨新适应症开发。 （丽珠集团公告） ...

康欣新材料股份有限公司公告，拟通过全资子公司湖北康欣科技开发有限公司(以下简称"科技公司")转 让位于陕西洋县、西乡、凤县、石泉、留坝、平利等6个区域的林地资产(以下合称"标的资产")，包括 林木资产及林地使用权资产，该资产价值主要包括科技公司的林地使用权资产价值及相应的林木资产价 值，总账面价值约为12.03亿元。 ...

Core Viewpoint - The company has signed a mortgage contract with its controlling shareholder, Chengdu Xingcheng Investment Group, and completed the mortgage procedures, using its assets to provide collateral valued at over 10% of the company's audited net assets for 2024 [1] Group 1 - The company has entered into a mortgage agreement with Chengdu Xingcheng Investment Group [1] - The mortgage procedures have been completed recently [1] - The collateral provided by the company exceeds 10% of its audited net assets for the year 2024 [1]

腾讯云AI漫剧解决方案支持腾讯混元等众多头部大模型的一站式接入，通过独有的Prompt提示词优化与 多图参考技术，有效解决AI生成漫剧中人物长相不统一、画风突变的行业难题。同时，无论是将真人 短剧一键转化为动漫风格的"视频转绘"，还是基于图片的"PPT漫"，抑或是全AI生成的动态漫，该方案 均提供了成熟的场景化模板，大幅降低了制作门槛。 近日，腾讯云并推出一站式AI漫剧解决方案。该方案深度融合了腾讯云领先的AIGC生成能力与媒体处 理MPS技术，旨在解决漫剧行业普遍面临的生产和运营痛点，助力企业实现从剧本创作、视频生成到全 球化宣发的全链路提质增效。 针对AI漫剧制作中最为复杂的资产生成环节，腾讯云AI漫剧解决方案覆盖了从剧本生成、角色库搭 建、分镜绘制、AI配音、视频生成、画质增强的全流程自动化、智能化。 另外，AI生成的原始视频往往存在分辨率较低、画面崩坏等问题。通过腾讯云媒体处理MPS能力，可 以智能修复与增强AI生成内容，并且实现组合式降本。比如，依托大模型对视觉规律的深度解构，系 统能自动识别并重绘画面中的"崩坏点"，实现发丝级细节还原和光影逻辑修复。而且，通过"AIGC生成 低分辨率视频+腾讯云媒 ...

2025年5月下旬，港股三生制药股价单日暴涨超30%，子公司三生国健在A股市场更是连续四个交易日 斩获"20CM"涨停。点燃这场资本狂欢导火索的，是一笔高达60.5亿美元的对外授权合作交易——辉瑞 拿下其抗癌双抗药物SSGJ-707海外权益，仅首付款就达到12.5亿美元。 而这，仅仅只是拉开了全年BD热潮的序幕。 从三生制药和辉瑞的双抗交易刷新国内BD首付款记录开始，信达生物、舶望制药、恒瑞医药 （600276）等公司接连宣布与武田、诺华、GSK等跨国药企达成数十亿乃至上百亿美元的合作。 过去一年，"BD"无疑是医药行业贯穿全年的核心关键词。据医药魔方研报数据披露，2025年国内创新 药对外授权交易总交易额超1300亿美元，仅首付款就超70亿美元，在ADC、双抗、GLP-1等前沿赛道 上，更是展现出影响细分赛道未来格局的潜力。 除了金额的飙升，BD交易模式的演变同样反映出产业关系的变迁。从单纯的licenseout到New-Co和Co- co模式（共同开发、共同商业化），乃至于共建"风险共担、利益共享"的生态，从单纯的"卖产 品"到"卖平台"，传统药企强势崛起，中小biotech多点开花。 刘立鹤同样提到，相 ...